iLIVE Volunteer Study
NCT04678310 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 105
Last updated 2024-02-28
Summary
The aim of this study is to develop and evaluate the implementation of an international volunteer training programme to support patients dying in the hospital setting and their families. It has the following objectives:
1. Explore the experience and perceptions of the international hospital palliative and end of life care volunteer programme, including care delivery, from the perspectives of:
* Patients and their family members who receive the service
* Volunteers who deliver the service
* Health care professionals caring for patients who receive the service
2. Assess the implementation and impact of a hospital volunteer service for dying patients
Conditions
- Terminal Illness
Interventions
- OTHER
-
Support from the hospital palliative and end of life care volunteer service (developed for this study).
Hospital palliative and end of life care volunteer service: a volunteer service to provide support to patients dying in the hospital and their families. The volunteer service has been designed to provide presence and companionship to dying patients at the end of life, and their families.
Sponsors & Collaborators
- collaborator OTHER
-
University of Liverpool
lead OTHER
Principal Investigators
-
John E Ellershaw · University of Liverpool
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-11-01
- Primary Completion
- 2023-12-31
- Completion
- 2023-12-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
International Study on Treatment of Liver (HCC) Patients With IRE
NCT07192731 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Evaluation of the Efficacy of Long-acting Release Octreotide in Patients With Advanced Hepatocellular Carcinoma
NCT00241020 ·Status: COMPLETED ·Phase: PHASE3
-
MB07133 for the Treatment of Patients With Unresectable Hepatocellular Carcinoma
NCT06141096 ·Status: RECRUITING ·Phase: PHASE2
-
Lipiodol-TACE With Idarubicin for Hepatocellular Carcinoma
NCT05280444 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Application of mRNA Immunotherapy Technology in Hepatitis B Virus-related Refractory Hepatocellular Carcinoma
NCT05738447 ·Status: UNKNOWN ·Phase: PHASE1
-
Quality of Life in Patients Undergoing Embolization Using Yttrium Y 90 Glass Microspheres for Primary or Metastatic Liver Cancer
NCT00739167 ·Status: COMPLETED
-
Study of Y90-Radioembolization With Nivolumab in Asians With Hepatocellular Carcinoma
NCT03033446 ·Status: COMPLETED ·Phase: PHASE2
-
Trial of TG4023 Combined With Flucytosine in Liver Tumors
NCT00978107 ·Status: COMPLETED ·Phase: PHASE1
-
SorAfenib Versus RADIOEMBOLIZATION in Advanced Hepatocellular Carcinoma
NCT01482442 ·Status: COMPLETED ·Phase: PHASE3
-
The eValuation of Image Guidance of Stereotactic Body Radiotherapy Using Ultrasound: Assessment in Liver
NCT03592550 ·Status: UNKNOWN
-
Internal Radiation Therapy in Treating Patients With Primary Liver Cancer That Cannot Be Removed by Surgery
NCT00469963 ·Status: TERMINATED ·Phase: NA
-
Quality of Life in Patients With Liver Cancer Treated With Image-Guided Therapy
NCT00482586 ·Status: COMPLETED
-
Pilot Study of Irreversible Electroporation (IRE) to Treat Metastatic Liver Cancer & Cholangiocarcinoma
NCT01442324 ·Status: UNKNOWN ·Phase: NA
-
A Clinical Trial Evaluating the Safety and Efficacy of Intravenous CD-801 in Treating Advanced HCC Patients
NCT06418659 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Indocyanine Green Molecular Fluorescence Imaging Technique Using in Diagnosis and Treatment of Primary Liver Cancer
NCT05160740 ·Status: RECRUITING ·Phase: NA
-
OH2 Oncolytic Viral Therapy Via Transcatheter Intraarterial Infusion in Patients with Advanced Liver Cancer
NCT05698459 ·Status: RECRUITING ·Phase: PHASE1
-
Irreversible Electroporation(IRE) For Unresectable Portal Venous Tumor Emboli
NCT02333773 ·Status: COMPLETED ·Phase: NA
-
Clinical Study on the Efficacy of Acetazolamide Combined With Levamisole in the Treatment of HCC
NCT04611373 ·Status: UNKNOWN ·Phase: PHASE3
-
Ablation Combined With PD-1 in HCC: Phase II Study
NCT04652440 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Intravascular Radiofrequency Ablation of Sympathetic Nerves for the Treatment of Hepatocellular Carcinoma
NCT06694636 ·Status: RECRUITING ·Phase: NA
-
A Trial of Hepatic Arterial Infusion Combined With Bevacizumab and Sintilimab for Unresectable A-staged Hepatocellular Carcinoma in BCLC Classification (D-TRIPLET)
NCT05214339 ·Status: UNKNOWN ·Phase: PHASE2
-
To Evaluate the Safety and Efficacy of Microwave Ablation Therapy in Patients With Primary Liver Cancer
NCT04520906 ·Status: TERMINATED ·Phase: NA
-
Hepatocellular Carcinoma on Cirrhosis With Child A/B7 and Hepatic Intra Arterial Injection of Idarubicin/Lipiodol Emulsion
NCT03727633 ·Status: TERMINATED ·Phase: PHASE2
-
Comparison of Adjuvant Treatment With 177Lu-DOTATATE to Best Supportive Care in Patients After Resection of Neuroendocrine Liver Metastases
NCT05987176 ·Status: TERMINATED ·Phase: PHASE2
-
Percutaneous Irreversible Electroportion in Unresectable Liver Cancer Close to Diaphragmatic Dome
NCT02329106 ·Status: COMPLETED ·Phase: NA